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dpsonne@gmail.comAbstractBile acids are possible candidate agents in newly identified pathways through which energy
expendituremayberegulated.Preclinical studies suggest thatbileacidsactivate theenzymetype
2 iodothyronine deiodinase, which deiodinates thyroxine (T4) to the biologically active
triiodothyronine (T3). We aimed to evaluate the influence of bile acid exposure and incretin
hormones on thyroid function parameters in patients with type 2 diabetes. Thyroid-stimulating
hormone (TSH) and thyroid hormones (total T3 and free T4) were measured in plasma from two
human studies: i) 75 g-oral glucose tolerance test (OGTT) and three isocaloric (500 kcal) and
isovolaemic (350 ml) liquidmealswith increasing fat contentwith concomitantultrasonographic
evaluation of gallbladder emptying in 15 patients with type 2 diabetes and 15 healthy age,
gender and BMI-matched controls (meal-study) and ii) 50 g-OGTTand isoglycaemic intravenous
glucose infusions (IIGI) alone or in combination with glucose-dependent insulinotropic
polypeptide (GIP), glucagon-like peptide 1 (GLP1) and/or GLP2, in ten patients with type 2
diabetes (IIGI-study). Inboth studies, TSH levelsdeclined (P!0.01) similarly followingallmeal and
infusionstimuli. T3andT4concentrationsdidnotchange in response toanyof theappliedstimuli.
TSH levels declined independently of the degree of gallbladder emptying (meal-study), route of
nutrient administration and infusion of gut hormones. In conclusion, intestinal bile flow and i.v.
infusions of the gut hormones, GIP, GLP1 and/or GLP2, do not seem to affect thyroid function
parameters. Thus, the presence of a ‘gut–thyroid–pituitary’ axis seems questionable.Key Words
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.0 UEndocrine Connections
(2014) 3, 193–199IntroductionBile acids are water soluble, amphipathic molecules
synthesised in the liver from cholesterol. Upon meal
ingestion, the gallbladder contracts, whereby bile acids from
the liver and highly concentrated bile acids from the
gallbladder are released into to the intestinal lumen. Herethey interact with dietary lipids, lipid-soluble vitamins and
cholesterol, forming mixed micelles, and thereby facilitating
the transport and uptake of these molecules (1). Nowadays,
bile acids are no longer labelled as detergents necessary for
lipiddigestionandabsorption,butare increasingly recognisedsed under a Creative Commons
nported License.
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2–7 3 :194as metabolic integrators, capable of regulating glucose
homeostasis, lipid metabolism and energy expenditure
throughnuclear receptors and theGprotein-coupled receptor
TGR5 (2, 3, 4). A study by Watanabe et al. (4) carried out in
mice showed that cholic acid supplementation augmented
energy expenditure in brown adipose tissue, caused weight
reduction and improved insulin sensitivity. The effects
were mediated through TGR5-induced intracellular cAMP
formation and activation of the intracellular type 2 iodo-
thyronine deiodinase (D2), which converts thyroxine (T4)
into the active thyroid hormone triiodothyronine (T3).
Up to date, human studies have yielded conflicting
results regarding the association between circulating bile
acids and thyroid function parameters. Patti et al. (5) have
found that bile acids in serum correlated inversely with
thyroid-stimulatinghormone (TSH) innon-diabeticpatients
who had undergone Roux-en-Y gastric bypass surgery, and
recent reports have demonstrated similar associations of bile
acids with TSH in type 2 diabetes (6, 7, 8). In contrast, Brufau
et al. (9) could not demonstrate any effect of bile acids on
energy expenditure in patients with type 2 diabetes.
Recently, Ockenga et al. (8) showed that TSH concentrations
decreased post-prandially in both patients with liver
cirrhosis and healthy controls, and the result furthermore
indicated that post-prandial bile acids are capable of
increasing D2 activity, which in turn converts T4 into T3
presumably suppressing TSH upon meal intake. Such
inhibitory effect of nutrient ingestion on TSH secretion in
humans has been sparsely reported in the literature (10, 11).
As meal-stimulated gallbladder emptying leads to prompt
elevations of plasma bile acids concentrations (12, 13), we
speculatedwhethervariousdegreesofgallbladderemptying–
induced by meals with a wide range of fat content – would
modulate thethyroidhormoneaxis accordingly inboth type
2diabetes patients andcontrols.Moreover, in a second study
in type 2 diabetes patients, using oral glucose tolerance test
(OGTT) and isoglycaemic intravenous glucose infusions
(IIGI), we analysed i) whether i.v. glucose per se could affect
thyroid function parameters and ii) whether any changes
could be elicited by infusion of the gastrointestinal
hormones glucose-dependent insulinotropic polypeptide
(GIP), glucagon-like peptide 1 (GLP1) and GLP2, which are
known to be secreted after nutrient ingestion.Subjects and methods
Meal-study
Detailed description of the experimental procedures
and subjects was provided previously (14). In short,http://www.endocrineconnections.org
DOI: 10.1530/EC-14-0088
 2014 The authors
Published by Bioscientifica Ltdmeasurement of TSH, total T3 and free T4 was carried out
with chemiluminescence immunoassays in the plasma
from 15 patients with type 2 diabetes (mean duration of
diabetes, 7.5 years (range 6–20); age, 59.4G9.6 years
(meanGS.D.); BMI, 28.0G2.2 kg/m2 and HbA1c, 7.5G
1.4%) and 15healthy age, gender and BMI-matched control
subjects (age, 59.7G10.0 years; BMI, 27.9G2.0 kg/m2 and
HbA1c, 5.2G0.2%) undergoing four separate ‘meal’ tests: a
75 g-OGTT and three isocaloric (500 kcal) and isovolaemic
(350 ml) liquid meals (low fat: 2.5 g fat, 107 g carbohydrate
and 13 g protein; medium fat: 10 g fat, 93 g carbo-
hydrate and 11 g protein and high fat: 40 g fat, 32 g
carbohydrate and 3 g protein). Four type 2 diabetes patients
were treated with diet alone, eight were also treated with
metformin and three with sulphonylurea (any oral anti-
diabetic therapy was omitted for a period of no less than a
week before each study day). Gallbladder emptying was
evaluated by calculating gallbladder ejection fraction using
ultrasoundmeasurements as previously described (14).IIGI-study
Detailed experimental procedures and patient charac-
teristics were reported previously (15). In short, measure-
ment of TSH, total T3 and free T4 was carried out with
chemiluminescence immunoassays in plasma from ten
patients with type 2 diabetes (mean duration of diabetes,
4.8 years (range0.5–14); age, 50.8G10.7years (meanGS.D.);
BMI, 33.2G4.9 kg/m2 and HbA1c, 6.5G0.7%) undergoing
six separate test days: 50 g-OGTT, IIGICsaline (placebo),
IIGICGIP, IIGICGLP1, IIGICGLP2 and IIGICGIPC
GLP1CGLP2 (saline and peptides were infused intrave-
nously). Nine patients were treated with metformin
alone and one with metformin and sulphonylurea in
combination (any oral antidiabetic therapy was omitted
for a period of not less than a week before each study day).
All participants gave their informed consent to the
studies, which were performed in accordance with the
Declaration of Helsinki and Danish legislation.Calculations and statistical analyses
The results are reported as means with 95% CIs unless
otherwise stated. For evaluation of TSH suppression
within groups, repeated measures two-way ANOVA with
Dunnet’s post hoc test was used (mean baseline concen-
trations were chosen as control mean). For between-group
comparison of TSH responses, area under the curve (AUC)
was calculated by applying the trapezoid rule for TSH.
For analysis of variations and differences between AUCThis work is licensed under a Creative Commons
Attribution 3.0 Unported License.
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3–7 3 :195values, repeated measures ANOVA with Sidak’s post hoc
test was used. The data were transformed logarithmically
(log10) to approximate a Gaussian distribution. A two-
sided P!0.05 was used to indicate significant differences.Results
Meal-study
As previously reported, gallbladder ejection fraction
increased similarly in the two groups with increasing meal
fat content (with similar ejection fraction following the
medium fat meal and the high fat meal nevertheless) (14).
BaselineTSHlevelswerewithinnormal range (0.3–4.0 mIU/l)
in all participants. As shown in Fig. 1, AUC levels and
basal TSH concentrations were higher in controls vs type 2
diabetes patients during oral glucose (P!0.05, Fig. 1); a
tendency to this was also seen during the meal stimuliMea
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Figure 1
Meal-study. Plasma levels of thyroid-stimulating hormone (TSH), thyroxine
(T4) and thyroid hormone triiodothyronine (T3) during a 75 g-oral glucose
tolerance test (OGTT) and three isocaloric (500 kcal) and isovolaemic
http://www.endocrineconnections.org
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Published by Bioscientifica Ltd(PZ0.05–0.09). TSH levels declined significantly after the
applied stimuli in both groupswithmaximumchanges from
baseline amounting toK0.54 UI/l (K0.75,K0.33) (OGTT),
K0.59 (K0.78, K0.41) (low fat), K0.62 (K0.84, K0.39)
(medium fat) and K0.70 (K1.10, K0.34) (high fat) in the
type 2 diabetic group and K0.96 (K1.40, K0.53) (OGTT),
K0.75 (K1.06, K0.45) (low fat), K0.92 (K1.33, K0.51)
(medium fat) and K0.76 (K0.99, K0.52) (high fat) in
controls, with no statistical significant differences within or
between groups. Neither, incremental AUC values differed
within or between groups. The concentrations of T3 and T4,
respectively, were similar in the two groups and did not
change after any of the oral stimuli.IIGI-study
TSH declined similarly on all study days following oral
glucose intake and all of the i.v. stimuli respectively.l-study
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(350 ml) liquid meals with low fat, medium fat and high fat, in healthy
control subjects (nZ15, closed symbols) and patients with type 2 diabetes
(nZ15, open symbols). MeanGS.E.M. values are shown.
This work is licensed under a Creative Commons
Attribution 3.0 Unported License.
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Figure 2
IIGI-study. Plasma levels of thyroid-stimulating hormone (TSH), thyroxine
(T4) and thyroid hormone triiodothyronine (T3) during 50 g-oral glucose
tolerance test (OGTT) and isoglycaemic intravenous glucose infusions (IIGI)
with concomitant infusions of saline, glucose-dependent
insulinotropic polypeptide (GIP), glucagon-like peptide 1 (GLP1), GLP2 or
a combination of the three hormones in patients with type 2 diabetes
(nZ10). MeanGS.E.M. values are shown.
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4–7 3 :196Accordingly, maximum changes from baseline amounted
toK0.76 (K1.15,K0.37) (OGTT),K0.56 (K0.79,K0.33)
(IIGICsaline), K0.64 (K0.89, K0.38) (IIGICGIP), K0.57
(K0.82, K0.32) (IIGICGLP1), K0.55 (K0.82, K0.28)
(IIGICGLP2) and K0.63 (K0.92, K0.34) (IIGICGIPC
GLP1CGLP2), with no statistical significant differences
between the different study days. Also, values of AUCs
were similar during the different study days (Fig. 2). The
concentrations of T3 and T4, respectively, were
comparable along the entire time course on all study
days. Neither suppression nor elevation of T3 or T4 was
demonstrated.Discussion
This study demonstrates a similar degree of TSH suppres-
sion in type 2 diabetes patients and healthy controls to
oral glucose and isocaloric and isovolaemic meals with
increasing fat content (giving rise to different gallbladder
emptying rates), and suggests that the oral route of
nutrient administration and subsequent release of the
gut hormones, GIP, GLP1 and GLP2 do not seem to play
a major role in post-absorptive TSH suppression. To our
knowledge, no previous study has compared thyroid
function parameters following both OGTT and various
meal tests (isocaloric and isovolaemic) affecting gallblad-
der emptying differentially in type 2 diabetes patients and
matched healthy controls, or thyroid function parameters
after oral and i.v. glucose in type 2 diabetes.
In both studies, basal and stimulated TSH concen-
trations were within normal range, but tended to be lowerhttp://www.endocrineconnections.org
DOI: 10.1530/EC-14-0088
 2014 The authors
Published by Bioscientifica Ltdin type 2 diabetes patients vs controls (meal-study). This
contrasts to the common observation of subclinical
hypothyroidism in type 2 diabetes patients (16, 17).
Interestingly, recent data indicates that metformin may
suppress TSH concentrations in type 2 diabetes patients,
thus providing a plausible explanation of the low(er) TSH
levels in our type 2 diabetic patients (18). However,
contrasting results have also been reported (19). In spite
of the observed TSH suppression, concentrations of T3 and
T4 did not exhibit post-prandial changes and were similar
in type 2 diabetes patients vs controls. This is supported by
a previous study in hypothyroid patients, showing that T3
and T4 were relatively insensitive to small alterations in T4
(administered daily) compared with TSH, which was very
sensitive to fine adjustments of T4 dosage (20). The notion
of oral glucose eliciting a similar degree of TSH suppres-
sion as compared with IIGI suggests that gastrointestinal
factors are less likely to play a role in nutrient-induced TSH
suppression. Supporting this notion, possible candidate
‘gut factors’, such as GIP, GLP1 and GLP2, infused
intravenously during IIGI neither altered the suppression
pattern of TSH or thyroid hormones. By contrast, a
previous study indicated that peripheral T3 formation
was stimulated by oral, but not by i.v., glucose suggesting
that the intestine or liver might involve in the regulation
of T3 formation (21).
As plasma bile acid concentrations reflect intestinal
bile acid absorption, as the fractional hepatic uptake of
bile acids is constant (13), the degree of gallbladder
contraction can be considered an ‘indirect’ measure of
the amount of bile acids that reaches the systemicThis work is licensed under a Creative Commons
Attribution 3.0 Unported License.
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5–7 3 :197circulation (‘spill-over’ from liver). On the basis of this
assumption, our results do not support a role for post-
prandial bile acids in modulating bile acid–TGR5-D2
activation in peripheral tissues (skeletal muscle and
brown adipose tissue). However, we acknowledge that
the study design does not allow drawing causal inferences
in this regard. Indeed, gallbladder emptying and even
bile acids provide only surrogate information of the
complexity of the enterohepatic circulation of bile acids
even though both are positively correlated with portal
venous concentrations (22).
A prompt inhibitory effect of nutrient ingestion on
TSH secretion in humans has been sparsely reported in
the literature (8, 10, 11) and the mechanism underlying
the suppression of TSH after ingestion of meals or glucose
remains to be established. In fact, TSH concentrations are
generally believed to decrease following long-term fasting
and increase upon refeeding (23, 24, 25). Considering
the role of gallbladder emptying and systemic bile acid
fluctuations, bile acid–TGR5 signalling might, as
hypothesised by Ockenga et al., acutely activate D2 in
pituitary thyrotropes, which are known to express D2 (26)
and possibly TGR5 (8), resulting in feedback on TSH upon
meal challenge. Importantly, such activation of D2 may
also be potentiated from the skeletal muscle where D2
activity is sufficiently high that it can provide significant
quantities of circulating T3 (27). Intriguingly, in rodents
TGR5 expression has been described in the paraventricular
nucleus and in the supraoptic nucleus of the hypo-
thalamus, suggesting that bile acid–TGR5 signalling may
regulate the thyroid axis at the level of thyrotropin-
releasing hormone (8, 28). In support of this, Ockenga
et al. (8) demonstrated an association between bile acid
and TSH concentrations after a nutrient challenge
(0–60 min) and found a close correlation between meal-
stimulated bile acid levels and energy expenditure after
60 min (most evident in patients with liver cirrhosis).
However, D2 activation might also simply be enhanced
by nutrients – especially glucose (29, 30) – reaching the
systemic circulation either via the oral route or during i.v.
stimulation. Interestingly, this is corroborated well in
another human study, which showed that 62 h of fasting
reduced D2 mRNA expression in skeletal muscle, whereas
5 h of insulin infusion increased D2 mRNA expression (at
62 h) (31). However, D2 activities were very low and were
not influenced by hypothyroidism, fasting or insulin.
Another explanation for the acute post-prandial TSH
decline observed in this study could be somatostatin being
released concomitantly from the intestine and/or hypo-
thalamus upon nutrient stimulation (10, 11, 32).http://www.endocrineconnections.org
DOI: 10.1530/EC-14-0088
 2014 The authors
Published by Bioscientifica LtdHowever, the physiological role of somatostatin for the
inhibition of TSH secretion in man has been questioned
(33). Accordingly, our observation of i.v. glucose infusions
suppressing TSH levels to similar levels as observed during
oral glucose argues against gut-derived somatostatin
playing a role in post-prandial inhibition of TSH release.
In contrast, hypothalamic somatostatin secretion could
have been stimulated during both oral and i.v. glucose and
thereby contribute to the observed TSH suppression
patterns (11). Also, as GIP and GLP1 increase somatostatin
secretion, at least in animals (34), suppression of TSH
during incretin infusion might have been augmented,
which, however, was not demonstrated in this study.
Moreover, hypoglycaemia, which is known to suppress
somatostatin levels, has also been shown to reduce TSH
concentrations (35), indicating that other factors apart
from somatostatin are responsible for TSH suppression
under normal physiological circumstances.
Finally, TSH concentrations display pronounced circa-
dian changes – typically with nocturnal increases and
daytime nadirs, which might also offer an explanation for
the decline observed after all stimuli (36). However, a recent
study in 475 000 outpatients has indicated that TSH
concentrations are constant from 0600 to 1900 h (37).
Accordingly, TSH baseline concentrations in this study
were similar, and suppression was noticeable only after the
nutrient stimuli were applied. Nonetheless, it remains an
obvious limitation to this study, as well as the study by
Ockenga et al. (8), that TSH concentrations were not
evaluated followingnon-nutrient stimuli (negative control).
In conclusion, patients with type 2 diabetes and
healthy controls display significant post-prandial TSH
suppression to a series of meal-related stimuli, but
independently of the degree of gallbladder emptying and
of the gut hormones GIP, GLP1 and GLP2. Obviously,
further studies are warranted to clarify whether bile
acids affect energy expenditure and diet-induced thermo-
genesis (via brown adipose tissue) in humans, but the
present findings do not support the presence of a ‘gut–
thyroid–pituitary’ axis.Declaration of interest
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